.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
US Department of Justice
Healthtrust
Farmers Insurance
Mallinckrodt
Boehringer Ingelheim
Queensland Health
Fish and Richardson
AstraZeneca
Moodys

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207953

« Back to Dashboard
NDA 207953 describes YONDELIS, which is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the YONDELIS profile page.

The generic ingredient in YONDELIS is trabectedin. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trabectedin profile page.

Summary for NDA: 207953

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 207953

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 207953

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
YONDELIS
trabectedin
POWDER;IV (INFUSION) 207953 NDA Janssen Products, LP 59676-610 59676-610-01 20 mL in 1 VIAL, SINGLE-USE (59676-610-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength1MG/VIAL
Approval Date:Oct 23, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 23, 2020
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Oct 23, 2022
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Jan 7, 2028Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Deloitte
US Army
Mallinckrodt
US Department of Justice
Covington
Farmers Insurance
Baxter
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot